# OnCo record chromophobe-rcc (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/chromophobe-rcc/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "chromophobe-rcc" ;
  schema:name "Chromophobe renal cell carcinoma"@en ;
  schema:alternateName "chRCC"@en ;
  schema:description "Chromophobe kidney cancer comes from a different cell of the kidney's tubules, usually behaves gently and is cured by surgery. Its rare metastatic form responds poorly to immunotherapy, so kinase and mTOR inhibitors are used, and it runs in families with Birt-Hogg-Dube syndrome."@en ;
  schema:url <https://onco.cc/cancers/chromophobe-rcc/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Chromophobe_renal_cell_carcinoma> ;
  schema:citation <https://en.wikipedia.org/wiki/Chromophobe_renal_cell_carcinoma> ;
  onco:tag "subtype-page" ;
  onco:related <https://onco.cc/cancers/clear-cell-rcc/>, <https://onco.cc/cancers/papillary-rcc/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-who-2022-gu-moch-eur-urol-2022/>, <https://onco.cc/key-papers/paper-tcga-chromophobe-davis-cancer-cell-2014/>, <https://onco.cc/key-papers/paper-aspen-armstrong-lancet-oncol-2016/> ;
  onco:pipeline <https://onco.cc/drugs/lenvatinib/>, <https://onco.cc/drugs/everolimus/> ;
  onco:standardOfCare <https://onco.cc/technologies/thermal-ablation/>, <https://onco.cc/technologies/active-surveillance/>, <https://onco.cc/drugs/sunitinib/>, <https://onco.cc/drugs/cabozantinib/>, <https://onco.cc/drugs/everolimus/>, <https://onco.cc/drugs/lenvatinib/>, <https://onco.cc/cancers/rcc/> .
